Afficher la notice abrégée

dc.contributor.editorPruitt, Joseph A.
dc.date.accessioned2021-04-20T15:17:55Z
dc.date.available2021-04-20T15:17:55Z
dc.date.issued2012
dc.identifierONIX_20210420_9789533078212_820
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/65463
dc.description.abstractMyasthenia gravis is presently an incurable antibody-mediated autoimmune disorder characterized by generalized voluntary skeletal muscle weakness. The cause of the weakness is a defect at the neuromuscular junction level, in which autoimmune antibodies block the receptors responsible for initiating muscular contraction. Literally translated from its Latin and Greek etymological roots, myasthenia gravis means "grave muscle weakness". Fortunately, advances in modern medicine have resulted in a reduction of the truly "grave" outcomes for those inflicted but, without a cure, the gravity surrounding the disease remains
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCM Immunologyen_US
dc.subject.otherImmunology
dc.titleA Look into Myasthenia Gravis
dc.typebook
oapen.identifier.doi10.5772/1243
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9789533078212
oapen.relation.isbn9789535167020
oapen.imprintIntechOpen
oapen.pages116


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/